Funded Project Details - FY2021
|Title:|| Microbiomal Mediators of TL1A-induced-Fibrosis|
||West Los Angeles, CA
|Congressional District Code:
||Clinical Science R&D
|| July 2021 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
ABSTRACT Inflammatory Bowel Disease (IBD) results from a series of complex interactions between susceptibility and severity genes, the environment and the mucosal immune system, presenting as clinical disease. The gut microbiome contributes to IBD; altered gut microbial composition has been demonstrated in intestinal inflammation, but few studies have examined intestinal fibrosis. A vast number of potential genetic, epigenetic and microbiotic variables contribute to the severity of IBD phenotype...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.